Breath Therapeutics

About:

Breath Therapeutics is a private clinical-stage biopharmaceutical company.

Website: http://breath-therapeutics.com/

Twitter/X: BreathTx

Top Investors: Sofinnova Partners, Gimv, Gilde Healthcare

Description:

Breath Therapeutics – a Zambon Group Company is pursuing groundbreaking therapies by unleashing the true potential of inhaled drug delivery. Their approach combines novel formulations of existing drugs with cutting-edge inhalation technology for the treatment of rare respiratory diseases with high unmet medical need. They are developing drug-device combinations designed to rapidly deliver high concentrations of drugs to the site of action in the lung. Their approach increases effective dosing in the lung while minimizing systemic exposure which could lead to new treatment solutions with enhanced efficacy and safety.